Tahan, V. Et Al. 2009. Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?. HEPATO-GASTROENTEROLOGY , vol.56 , 1425-1428.

Tahan, V., Ozaras, R., Karaca, C., Uraz, S., EREN, F., Danalioglu, A., ... Avsar, E.(2009). Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?. HEPATO-GASTROENTEROLOGY , vol.56, 1425-1428.

Tahan, Veysel Et Al. "Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?," HEPATO-GASTROENTEROLOGY , vol.56, 1425-1428, 2009

Tahan, Veysel Et Al. "Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?." HEPATO-GASTROENTEROLOGY , vol.56, pp.1425-1428, 2009

Tahan, V. Et Al. (2009) . "Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?." HEPATO-GASTROENTEROLOGY , vol.56, pp.1425-1428.

@article{article, author={Veysel Tahan Et Al. }, title={Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?}, journal={HEPATO-GASTROENTEROLOGY}, year=2009, pages={1425-1428} }